May 18, 2022 – from The Times of Israel
The Israel Space Agency and the Ministry of Innovation, Science & Technology announced a plan to spend $180 million over the next five years to support new startups in the space sector. The funding is part of a greater initiative from the Israel government to double the number of civilian space companies and quadruple the number of workers in the space industry in Israel.
May 17, 2022 – from NoCamels
Israeli auto tech startup REE Automotive has announced plans to build a new manufacturing facility in the United Kingdom featuring assembly lines staffed fully by autonomous robots. The facility will be able to manufacture the company’s electric and autonomous vehicle chassis in less than a minute with an oversight staff of just seven human workers.
May 17, 2022 – from ISRAEL21c
“Tiny AI” technology developed by Israeli company Emza Visual Sense is being integrated into several series of new Dell laptops. The technology is designed to visually detect user engagement levels with machine learning and neural network-based algorithms, increasing security and power management capabilities in the device.
May 16, 2022 – from U.S. Department of Energy
Israel’s Ministry of Energy and the U.S. Department of Energy announced a new round of $4 million of available funding for the development of new technologies to produce clean energy. Funding will be awarded to projects that scale up carbon-free technologies or that reduce the climate impact natural gas infrastructure.
May 15, 2022 – from Tel Aviv University News
A new study from Tel Aviv University found that women aged 55 and over who snore are at increased risk for sleep apnea, which causes a decrease in blood-oxygen concentration and can be dangerous. Researchers recommend vigilance by doctors, dentists, and other health professionals to identify warning signs of sleep apnea in patients.
May 12, 2022 – from The Times of Israel
Hebrew University scientists have outlined a mechanism that harms eggs in zebrafish and mice when malfunctioning. The danger in the pathway occurs when the organization of chromosomes in the egg is defective, opening the door for further research into fixes for the defect.
May 12, 2022 – from The Jerusalem Post
Researchers at Sheba Medical Center have found that the bite of an invasive species of fire ants could threaten lives for the first time. Doctors found that a patient’s recurring, life-threatening symptoms were most likely caused by fire ant bites, prompting calls for better measures to contain or eradicate the invasive ants.
May 11, 2022 – from Ben-Gurion University of the Negev
Biopharmaceutical company Madrigal Mental Care launched a new treatment for post-traumatic stress disorder (PTSD) utilizing nanotechnology developed by researchers at Ben-Gurion University of the Negev. The system involves a nasal spray that enables “nose-to-brain delivery of organic nanoparticles” in safe and precise doses.
May 10, 2022 – from Weizmann Wonder Wander
Scientists at Weizmann Institute of Science have captured and analyzed bundles of RNA molecules that function in tandem in gene expression, but that originate from different chromosomes. The study also found that when these bundles were perturbed, the cellular process the genes belong to were disrupted, indicating that this grouping method is widely used in eukaryotic cells.
May 9, 2022 – from ISRAEL21c
Israeli company PixCell has developed a new device to perform fast and accurate at-home blood tests. The device, dubbed HemoScreen, is capable of producing lab-accurate test results from a single finger-prick in less than five minutes, allowing immunocompromised individuals to limit their time in hospital settings.
May 3, 2022 – from ISRAEL21c
Israeli company OmnySense has developed a household thermometer that also measures the user’s respiratory rate, pulse, ECG and blood oxygen, giving users a more complete picture of their physical condition. The data is uploaded to the cloud for further analysis through a free app, applying niche health-tracking solutions to general use.
May 3, 2022 – from The Times of Israel
Israel-based company High Hopes Lab is developing a specialized balloon that could be the world’s first scalable method for capturing carbon from the atmosphere. The balloon separates carbon from wind blowing through the balloon, stored in a freezer compartment, and transformed to carbon dioxide gas as the balloon descends, all costing less than $50 per ton.
May 2, 2022 – from PR Newswire
Israeli medical device company Limaca Medical has received a Breakthrough Device designation from the FDA for its motorized, automated endoscopic biopsy device. The tool is designed to collect tumor tissue samples within or adjacent to the gastrointestinal tract without manual hand operation, the first of its kind, making the procedure quicker and leaving less trauma to the biopsied area.
April 30, 2022 – from The Jerusalem Post
Israel’s Transportation Ministry approved the use of a traffic signal controls and analysis system for use in traffic planning in Jerusalem and Tel Aviv. The software simulates car, scooter, and pedestrian traffic to optimize traffic at every intersection in the city, reducing air pollution by optimizing wait times.
April 28, 2022 – from The Times of Israel
A peer-reviewed study from Bar-Ilan University theorizes a large part of learning occurs in dendrites rather than synapses, going against previous understanding of the structure and function of neurons. The findings may encourage more research into dendrite learning, with applications in drug development for neurodegenerative diseases such as Alzheimer’s and Parkinson’s as well as computing and machine learning.
April 27, 2022 – from NoCamels
A joint research project from four Israeli higher education institutions has developed a technology that scans, models, and artificially replicates coral reefs using 3D printing. The modelling technology will help scientists better understand the types of biodiversity reefs can support, as well as 3D print new structures to replace damaged natural reefs.
April 26, 2022 – from The Times of Israel
Startup company SolCold has signed an agreement with automaker Volkswagen to test its eco-friendly cooling technology and to develop a concept vehicle. The technology conducts solar energy into subatomic particles that lose heat, creating a cooling, multi-layer film to be applied to cars, buildings, or containers to help regulate their temperature in warm, sunny environments.
April 25, 2022 – from ISRAEL21c
Israeli startup RedC Biotech is aiming to produce large supplies of blood for use in medical settings from a single “universal” stem cell donor. The process, like growing cultured meat products, would ease the strain on blood banks and ensure a blood supply for patients needing transfusions. Clinical trials on the synthetic blood are expected to begin in the next three years.
April 24, 2022 – from The Jerusalem Post
A new accelerator program called Game Hub hopes to provide support to Israeli developers of games with both cultural and commercial value. The program provides financing opportunities, workspace, and mentorship from game development professionals to new and developing companies, in collaboration with several Jerusalem organizations including the Jerusalem Development Authority and Hebrew University.
April 24, 2022 – from Tel Aviv University News
Tel Aviv University scientists have identified a mutant strain of microscopic algae capable of producing “green” hydrogen on an industrial scale via photosynthesis, the first such discovery in the world. While much of the hydrogen used for fuel is “gray” hydrogen, produced via natural gas that emits harmful greenhouse gases, the algae produce hydrogen free of carbon dioxide emissions and can sustain production continuously for more than 12 days.
April 21, 2022 – from The Times of Israel
Amazon has invested in Israeli robotics company BionicHIVE, the makers of an automated warehouse system based on synchronized autonomous robots. The system can “sort, select, and put away packages, navigate warehouse floors using in-built cameras and sensors, and move between people and objects” without human intervention, with immediate applications for supply chain facilities.
April 20, 2022 – from ISRAEL21c
Netanya-based startup Pentaxi is developing a pilotless electric vertical takeoff and landing craft for carrying both cargo and passengers. The aircraft relies on advanced flight control systems to orchestrate five independently moving engines with a special tilt mechanism for vertical takeoff and landing and smooth flying. The company hopes to launch their cargo model in 2025.
April 20, 2022 – from The Jerusalem Post
Israeli company AI21 Labs has developed a new system of Natural Language Processing, AI’s ability to understand human speech and language, capable of deeper understanding of natural language. The system enables AI to move away from pretrained language models, which are only updated every few years, toward continuous learning, and makes improvements in the AI’s reasoning ability.
April 18, 2022 – from NoCamels
AI-based construction startup Ception unveiled a new real-time, 3D visual mapping system to provide better awareness to operators of heavy machinery for construction projects. The system uses visual feeds from cameras, cross-referenced by sensors, processing algorithms, and deep learning to provide an accurate picture of the machine’s surroundings, decreasing the likelihood of accidents.
April 16, 2022 – from Technion - Israel Institute of Technology
A Technion research team successfully created edible muscle fibers by bioprinting living animal cells on a plant-based scaffold, a milestone in efforts to produce cultivated meat for human consumption. The technology from the project will contribute to efforts to meet the growing demand for meat products that are less detrimental to the environment.
April 14, 2022 – from The Times of Israel
A joint program between the South Korean Ministry of Trade, Industry and Energy and the Israel Innovation Authority will offer up to $5.3 million per joint project between the two nations on the development of robotics technologies. Dubbed the “Lighthouse Program”, the funding opportunity will place special emphasis on projects in the health, logistics, agriculture and livestock, and domestic services fields.
April 14, 2022 – from The Jerusalem Post
Israel’s Defense Ministry conducted a series of successful experiments testing their groundbreaking laser areal defense system. The first energy-based weapons system in the world, the laser is claimed to be “effective, accurate and easy-to-operate” while also offering a large cost savings over current missile defense systems.
April 12, 2022 – from NoCamels
The Israel Innovation Authority approved a budget committing $17.8 million to two consortiums designed to develop “technologies for human-robot interaction” and to advance “command and control capabilities of autonomous vehicle fleets.” The funding will be distributed via grants to local companies and research institutions with promising research and development projects in the fields.
April 11, 2022 – from Technion - Israel Institute of Technology
A research study by a pair of Technion scientists sheds light on the exceptionally fast rate of DNA unwinding by the RecBCD enzyme during DNA repair. The project discovered additional ATP binding sites on the enzyme, serving as a “funnel” to the catalytic site. The discovery may have implications in the study of both enzyme catalysis and of DNA repair.
April 11, 2022 – from Tel Aviv University News
Researchers from Tel Aviv University have shown that common dietary supplements can offer protection from Covid-19, as well as several other common illnesses. The study found that the combination of zinc with flavonoids found in many fruits and vegetables helps protect cells against a variety of RNA viruses, with a 50-95% reduction in genetic replication of the viruses.
April 7, 2022 – from The Jerusalem Post
Psychology researchers from Reichman University in Herzliya have developed a new technology that helps people with severe hearing loss or deafness to experience speech and sound through touch. The device delivers speech and sounds through vibrations on the fingertips of the listener, with potential applications including auditory rehabilitation programs.
April 4, 2022 – from NoCamels
An international team of researchers, led by scientists from Ben-Gurion University of the Negev, developed a new combination of treatments for patients with advanced or metastatic head and neck cancer (HNC) to block a signaling pathway that suppresses the immune system. The team found the combination of drugs resulted in the disappearance of HNC tumors in mice, leaving researchers hopeful the treatment will be effective in clinical trials.
April 4, 2022 – from Weizmann Wonder Wander
A research team from Weizmann Institute of Science found that a subset of fibroblasts may play a role in the origin of the rare autoimmune disease scleroderma. The study examined skin samples from nearly 100 scleroderma patients and found that fibroblasts in patients differed greatly from the controls while immune abnormalities showed no characteristic pattern, providing new insight into the causes and potential treatments of the disease.
April 1, 2022 – from The Times of Israel
A study from Weizmann Institute of Science discovered a genetic mutation that appears to protect individuals against ALS. The research showed that people with a specific mutation in regions of non-coding DNA that halts or reduces brain inflammation have just one-fifth the chance of the general population of developing the disease. Future studies will attempt to mimic the mutation in patients to see if it has a positive effect on people sick with ALS.
March 30, 2022
From The Jerusalem Post - The US and Israeli governments announced a new funding cycle for carbon-free energy initiatives through The Binational Industrial Research and Development Foundation. The nations will invest up to $1 million per project for renewable energy research and development efforts involving at least one American and one Israeli company.
March 30, 2022 – from ISRAEL21c
Tel Aviv health coverage company Marpai is using machine learning, artificial intelligence, and neural networks to “predict who will get sick, what it will cost and who’s the best in-network physician.” The technology focuses on predictions rather than diagnostics, drawing on customer data to evaluate a patient’s risk of having certain medical issues in the future.
March 28, 2022
From Technion - Israel Institute of Technology - Technion – Israel Institute of Technology is collaborating with Rambam Hospital to form a joint Center for Artificial Intelligence in Healthcare. It will be the first joint academic-hospital AI center in Israel and will “develop advanced artificial intelligence systems to analyze a patient’s condition.”
March 28, 2022 – from NoCamels
Researchers from Weizmann Institute of Science unveiled Israel’s first quantum computer, one of just 30 machines in the world and one of less than 10 that use ion traps. The current five-qubit computer will be used to run advanced algorithms, while another, more powerful quantum computer with 64 qubits is in development to tackle computations unable to be performed by the largest classical computers.
March 28, 2022 – from Tel Aviv University News
A study from Tel Aviv University, Kaplan Medical Center, and Shamir Medical Center found over 25% of children discharged from an emergency room for a mild head injury are misdiagnosed, leading to post-concussion syndrome for several years following. The study followed 200 children that met the research criteria for periods ranging from six months to three years, finding about a quarter of them suffering from the chronic syndrome.
March 25, 2022 – from The Times of Israel
A team of Israeli scientists claim to have safely administer an effective but toxic immunotherapy drug to combat various cancers. The treatment enhances the effectiveness of the CD40 receptor using synthetic antibodies that have been engineered to apply itself very selectively, stimulating the immune system to fight many solid tumor cancers.
March 15, 2022 – from The Jerusalem Post
Israeli biotechnology company Tissue Dynamics claims it can cut the cost of drug development by 40-80%, and cut the time required by 30-50%, using their autonomous development platform. The process involves sensors placed in microfluidic models of human tissues made by robots, capable of analyzing the effect of new drugs on different modes of diseases, as well as their impact on normal tissues.
March 14, 2022 – from Jewish News Syndicate
Israeli company Steadicopter recently unveiled a new type of unmanned helicopter for surveillance, intelligence, and reconnaissance purposes, as well as carrying cargo payloads. The helicopters are powered by hybrid engines, utilizing both battery power and a generator providing electric propulsion, for uses ranging from search-and-rescue missions to offshore rig monitoring.
March 13, 2022 – from The Times of Israel
Israeli startup UVeye has been selected by Volvo to provide the car manufacturer with AI-powered inspection systems for select US retailers. The system uses cameras and sensors to scan a vehicle’s exterior and undercarriage and uses machine learning models to identify any mechanical flaws or foreign objects in just minutes.
March 10, 2022 – from ISRAEL21c
Researchers from Technion – Israel Institute of Technology have uncovered a mechanism of cancer metastasis activated by chemotherapy treatment. The team found that high amounts of LOX enzyme, a protein that makes lung tissue more hospitable for cancer cells, are secreted by T-cells in response to chemotherapy, a finding that could inspire new drug development and treatment that could prevent this phenomenon.
March 10, 2022 – from NoCamels
Israeli companies, including the Rehovot-based Lusix, are disrupting the diamond industry by manufacturing diamonds for jewelry in labs. The practice involves the heating of carbon-rich gasses to temperatures of 3000 degrees, creating a diamond “optically, chemically, physically and structurally identical to a mined diamond” while remaining more sustainable and eco-friendlier than traditional mining.
March 9, 2022 – from The Jerusalem Post
Israel and Bahrain signed a cooperation agreement for collaborations in the medical sector in each country. The agreement will enable the nations to share information and technology to better research and development, digital health, genetic research, and the ability of medical systems to cope with pandemic and medical emergencies.
March 8, 2022 – from The Times of Israel
A lab at Hebrew University of Jerusalem achieved the “reverse aging” of human eggs by uncovering an aging mechanism previously unknown and reversing the process through the administration of anti-viral drugs. The study provides hope that within 10 years, anti-viral drugs may be used to increase fertility in older women.
March 7, 2022 – from The Algemeiner
A new program sponsored by Israel’s Interior Ministry calls for the formation of “Innovation Teams” to “introduce new work processes and tools” to cities with significant populations of both Arab and Jewish people. The program initiatives will focus on “helping small businesses, enhancing civic hygiene, and improving transportation and connectivity.”
March 7, 2022 – from Ben-Gurion University of the Negev
BGU scientists were part of a research team that found the first evidence for a plate tectonic chain reaction. The researchers applied methods typically used for magnetic reversals to magnetic noise variations found after the formation of a new subduction zone north of Arabia, finding the African plate accelerated and rotated, causing a sequence of tectonic events in the western Mediterranean.
March 3, 2022 – from Ben-Gurion University of the Negev
BGN technologies announced the launch of a US-Israel consortium to protect energy sources and facilities from cyber attacks. Led by BGU and Arizona State University, the consortium will promote research and development collaboration between institutions focusing on the protection of manufacturing stages, storage, and energy distribution, with investments totaling $12 million.
March 3, 2022 – from ISRAEL21c
Researchers from the University of Haifa found that a genetic mutation protecting individuals from malaria was more prevalent in populations in Africa, where it is endemic, than in people from Europe where it is not. The results suggest genetic mutations are the result of the accumulation of complex information that are the response to long-term environmental pressures.
March 2, 2022 – from The Jerusalem Post
A study from Tel Aviv University discovered a treatment for the degeneration of bioprosthetic heart valve transplants made from animal tissue. Scientists found that genetically modifying the heart valves to stop producing foreign non-human sugars significantly reduced the immune response to these compounds that leads to calcification and degeneration 10-12 years after implantation.
March 1, 2022 – from Weizmann Wonder Wander
Researchers at Weizmann Institute of Science “found that the fingerprint of antiviral antibodies differed between mild and severe COVID-19 patients, and between recovering and vaccinated individuals.” The study identified distinct sugars attached to the tails of antibodies in each group, which positively “affect the quantity, quality and mode of protection achieved by vaccination, as compared to natural immunization.”
March 1, 2022 – from The Times of Israel
Biopharmaceutical company NeuroGenesis tested a new stem cell therapy targeted at multiple sclerosis patients that showed promise in small clinical trials. Nine of fifteen patients receiving injections into their spinal cord fluid showed decreased levels of NfL protein, considered a biomarker of the disease, and improved disability scores 12 months after the treatment, while only one of fifteen in the placebo group showed such improvement.
February 26, 2022 – from ISRAEL21c
Israel-based health tech company New Phase is developing a new treatment for stage 4 metastatic cancer that has the potential to transform the illness from a death sentence to a chronic illness. The treatment involves the injection of iron oxide nanoparticles, which selectively bind to tumors before being heated by non-ionizing radiation, taking advantage of the disorganized vascular structure of cancer cells to shrink metastatic growths.
February 22, 2022 – from Weizmann Wonder Wander
Weizmann Institute of Science researchers have uncovered the mechanism of the spread of certain types of aggressive breast cancers. Experiments showed large amounts of NUP93 proteins in breast cancer patients with poor survival records, which allows metastatic cancer cells to access the nucleus of healthy cells for replication and movement. Scientists hope these findings will lead to the improvement of targeted cancer treatments.
February 22, 2022 – from Tel Aviv University News
Researchers at Tel Aviv University and Shamir Medical Center were able to relieve symptoms of post traumatic stress disorder (PTSD) using a new method of treatment involving hyperbaric oxygen therapy. The study involved 35 combat veterans that suffered resistant PTSD and found improvement in all PTSD symptoms of the treatment group after 60 hyperbaric treatments.
February 22, 2022 – from NoCamels
PixCell Medical was awarded a grant from the International Health-Tech Pilot Program to further develop and expand the reach of their hematology testing system, HemoScreen. The instrument combines “novel microfluids, machine learning and AI into a point-of-care instrument anyone can operate” to accurately inform doctors on their treatment decisions based on real-time data from a patient’s blood test.
February 21, 2022 – from The Jerusalem Post
Israeli startup GEOX signed a commercial agreement with Japanese company Sompo International to use their product to better assess property damages due to natural disasters in Japan. The image analyzer uses artificial intelligence to assess a building’s risk of damage due to natural disaster, providing a more accurate insurance price assessment for customers.
February 20, 2022 – from ISRAEL21c
Israeli ag-tech startup Greeneye Technologies is helping curb the excessive use of herbicide on crops through their new approach to weed control. The company’s product turns ordinary machines into “smart sprayers” with the assistance of mounted cameras and artificial intelligence. The system can detect over 200 types of weeds with over 95% accuracy, enabling farmers to use the most effective herbicide and only where needed.
February 16, 2022 – from The Times of Israel
Israeli startup Healthy.io is hoping to expand the reach of their FDA-approved at-home urine analysis tests to the UAE. The product uses artificial intelligence and image recognition technologies to enable a smartphone camera to read urine test strips with clinical-grade precision.
February 16, 2022 – from Jewish News Syndicate
Israel’s Defense Ministry and the Israel Innovation Authority announced about $62 million in funding to develop Israel’s first quantum computer. The project aims to boost Israel to the front lines of computational innovation by increasing computing power, with potential applications in cybersecurity, pharmaceuticals, banking, finance, and advanced manufacturing.
February 16, 2022 – from NoCamels
Two Israeli companies are seeking to decrease sugar content in fruit juice to make them more viable as a healthy beverage option. Startup Blue Tree is developing a method to selectively remove certain sugars from juices, while Better Juice is using enzymes to degrade sugars of all kinds in juices to other compounds such as dietary fiber that does not change the sweet taste of the beverage.
February 15, 2022 – from Tel Aviv University News
A new study from Tel Aviv University associates abnormal brain activity during sleep and anesthesia as a symptom of Alzheimer’s that may show years before other symptoms. Researchers found increased activity in the hippocampus in Alzheimer’s model animals while under anesthesia, resemblant of the brain’s failure to regulate the neural network and offering a head start on treatment that could prove valuable to patients.
February 12, 2022 – from The Jerusalem Post
Israeli startup CytoReason has announced an extension to their partnership with pharmaceutical giant Pfizer to continue to bring their computational machine learning models to drug development. The technology collects proprietary data from pharmaceutical companies and uses it to simulate human diseases in specific tissues and cells, ultimately shortening trials, reducing costs, and identifying new drug opportunities.
February 9, 2022 – from The Jerusalem Post
DNA sequencing of plankton from deep-sea sediments is providing the first detailed picture of plankton biodiversity from all deep-ocean levels. The study confirmed that deep-ocean plankton are much more diverse than mid-level plankton and is allowing scientists to understand which members of plankton communities contribute the most to biological processes.
February 9, 2022 – from Ben-Gurion University of the Negev
A new study from Ben-Gurion University of the Negev and Soroka Medical Center found that a routine prenatal ultrasound can identify signs of autism spectrum disorder. The study examined hundreds of prenatal scans and found abnormalities in the heart, kidneys, and head in 30% of fetuses that developed autism, three times higher than the general population. The study may enable doctors to diagnose autism earlier and begin treatment at birth.
February 8, 2022
From The Times of Israel - Israeli startup HIL Applied Medical is implementing breakthrough technology developed at Hebrew University to deliver proton-beam radiotherapy to cancer patients at a fraction of the cost. Proton radiotherapy kills less healthy tissue than traditional X-ray or photon radiation treatments, improving both patient survival and quality of life. The new device cuts the total cost for hospitals from $30 million to $15 million, enabling more hospitals to adopt the method and to reduce treatment costs for patients.
February 3, 2022
From Tel Aviv University News - Researchers from Tel Aviv University successfully engineered the world’s first 3D human spinal cord tissue transplant. The study implanted the engineered tissues into a lab model with long-term chronic paralysis, demonstrating a high rate of success in restoring walking abilities. Scientists are preparing for clinical trials in human patients and hope their technology will help paralyzed patients walk again.
February 3, 2022 – from ISRAEL21c
Sheba Medical Center has partnered with AdOM Advanced Optical Technologies to test the company’s Tear Film Imager (TFI) device to detect Covid-19 on the surface of the eye. The device measures muco-aqueous and lipid sublayers of the eye’s tear film and is already used to diagnose other eye conditions. The study will test the device’s specificity and sensitivity compared to PCR tests on about 500 Covid patients over 30 days.
February 1, 2022 – from The Jerusalem Post
The world’s first fully autonomous store is set to open in the United States thanks to a “Smart Shelf” developed by Israeli company Shekel. The shelves include an advanced weighing system that, combined with artificial intelligence-based algorithms, can detect exactly what was removed from the shelf and add it to the customer’s virtual shopping cart, while performing the inverse function if an item is returned to the shelf.
January 31, 2022 – from Technion - Israel Institute of Technology
Technion researchers have developed a machine learning model that rectifies the underrepresentation of women in clinical trials of medical treatments. The algorithm uses natural language programming and vector representation of words to enable “gender-sensitive use of clinical literature” before correcting gender bias and thereby improving the suitability of treatments for female patients.
January 31, 2022 – from Weizmann Wonder Wander
Weizmann Institute of Science researchers have demonstrated the possibility of mapping real-time gene expression using colors by magnetic resonance imaging (MRI). The scientists developed a new method using MRI to simultaneously track the expression of two genes in different colors, opening the door for further development and application in areas such as therapies for cancer and stem cell treatments.
January 26, 2022 – from i24 News
Israel’s Space Agency officially signed an agreement with NASA to join the Artemis Accord, a program aimed at landing astronauts on the lunar surface and establishing a long-term human presence on the moon. Israel is the fifteenth country to sign the Artemis Accords, joining partner nations including Australia, Canada, the UAE, and the UK.
January 26, 2022 – from The Times of Israel
Researchers have discovered a pattern of specific antibody levels in Covid-19 patients that may enable doctors to identify patients that are more likely to suffer long COVID, caused by an immune response that attacks the body instead of the virus. Scientists hope their findings will “facilitate research, understanding, and ultimately targeted treatments for long COVID.”
January 25, 2022
From The Jerusalem Post - A remote electrical neuromodulation (REN) device made by Theranica proved safe and effective at treating migraine symptoms in the world’s largest prospective real-world study of such treatment. The device is placed on the upper arm and triggers conditioned pain modulation through REN, controlled by a smartphone. The study consisted of over 23,000 treatments over 20 months and found that over 65% of participants experienced pain relief after two hours.
January 24, 2022 – from Jewish News Syndicate
Researchers at Tel Aviv Sourasky Medical Center have discovered the pathway by which pancreatic cancer cells spread in the liver. The study found a mutation causing the absence of two key proteins, in greater severity in liver metastasis than in other areas of the body. Scientists hope the findings will lead to better treatments to prolong the lives of patients.
January 24, 2022 – from ISRAEL21c
Scientists at Reichman University in Herzliya are exploring connections between senses, including sensory substitution techniques requiring little training. Their work, including experiments on sensory linkage and the development of new devices, seeks to improve quality of life for both individuals with sensory disabilities and the general population.
January 23, 2022 – from Weizmann Wonder Wander
Researchers from Weizmann Institute of Science and Sheba Medical Center have developed a noninvasive method for detecting inflammation in the intestines. The method involves stool testing, as opposed to an invasive colonoscopy, to facilitate the diagnosis of Crohn’s disease and ulcerative colitis, among others.
January 23, 2022 – from The Times of Israel
Representatives from eleven Israeli startups will take part in Arab Health, an annual health technology exhibition in Dubai, to showcase their leading healthcare innovations. Participating companies will meet with representatives from South Korea, India, Japan, and Singapore, among others, with the goal of significantly strengthening exports of technology to improve the lives of patients around the world.
January 16, 2022 – from ISRAEL21c
Israeli startup Restore Medical has developed an implant to be inserted into the pulmonary artery of congestive heart failure patients to change the pressure of the healthy right ventricle to support a failed left ventricle. The implant procedure is relatively simple, taking just an hour, and can lead to a reduction of symptoms and hospital visits for patients.
January 15, 2022 – from The Times of Israel
New findings show that multiple sclerosis (MS) is largely driven by infection of the Epstein-Barr virus (EBV), the same virus that can cause infectious mononucleosis. The Harvard University study found a 32-fold increase in risk of MS after infection with the virus. Researchers hope targeting EBV could help lead to the discovery of a cure for MS.
January 13, 2022 – from NoCamels
Israel recently launched the fourth phase of their national drone initiative, allowing flights over urban areas to transport basic products, provide first aid and monitor traffic movement. The move is good news for startups like Percepto, who responded to hurricanes and wildfires in the past two years in the US by sending in autonomous drones to examine damage to power lines and communication infrastructure.
January 13, 2022 – from Technion - Israel Institute of Technology
Researchers at Technion – Israel Institute of Technology have developed a fast, efficient method for removing PFAS pollutants, known as “forever chemicals”, from drinking water. The technology combines oxidation processes and targeted polymers to increase efficiency to close to 90 percent, compared to current adsorption methods.
January 12, 2022 – from Weizmann Wonder Wander
Researchers at Weizmann Institute of Science recently detected a rare type of supernova that has never been observed before. Wolf-Rayet stars, characterized by the absence of light elements at the star’s surface, were theorized to collapse into black holes instead of a normal explosion that produces a supernova, a theory that was shattered with the team’s discovery and analysis of light emitted from the explosion of one of these stars.
January 11, 2022 – from The Washington Post
A study at Ben-Gurion University of the Negev successfully trained goldfish to use a wheeled platform that could be driven in reaction to the fish’s movements inside a water tank mounted on a platform using laser remote sensing technology. The fish were able to move the vehicle to a target while avoiding dead-ends and navigating past obstacles.
January 11, 2022 – from Jewish News Syndicate
A grant of nearly $6 million has been awarded to 11 Israeli companies developing innovative space technologies by the Israel Space Agency, the Israel Innovation Authority, and the Innovation, Science and Technology Ministry. The companies were selected for their innovation, research-and-development capabilities, and the competitive advantage their products offer.
January 9, 2022 – from The Times of Israel
Israeli water tech company Alumor has developed a household water purification system that it claims is “sustainable, cheap, easy to use, and could provide millions of households in developing countries with clean drinking water.” The system uses solar energy to power ultraviolet technology that kills viruses and bacteria often found in water sources in the developing world and purifies water for less than half a cent per liter.
January 5, 2022 – from Israel Hayom
Intel Israel is implementing new technology in its line of EVO laptops that will allow users to sync devices running on different platforms to their computer. The tech is designed to ease the user experience by improving the ability to transitioning data from one device to all kinds of others and to unify the capabilities of many devices into one.
January 3, 2022 – from ISRAEL21c
Two recently published studies show that symptoms of autism can be identified in infants as early as in the first year of life. The first study, from the Mifne Center for Early Intervention in the Treatment of Autism, showed that infants in which autistic behavior was observed were later diagnosed with autism between the ages of 2.5 and 3. The second study, from Bar-Ilan University, found that children with autism showed statistically significant improvement with therapeutic interventions beginning in their second year as opposed to their third.
January 3, 2022 – from The Jerusalem Post
The Israel Innovation Authority is launching a new measurement of social consciousness for companies, called the Environmental, Social and Governance Index (ESG). The criteria are designed to assist in the evaluation of opportunities for socially conscious investors while funneling more money into companies tasked with addressing issues such as “carbon reduction, employee diversification, corporate governance and modern slavery.”
January 2, 2022 – from Ben-Gurion University of the Negev
Scientists at Ben-Gurion University of the Negev have discovered the biological function of a peptide as a protein kinase inhibitor, the first in the world to do so. The research found a portion of “non-coding” mRNA that in fact contained a sequence for a short peptide that inhibits cancer cell survival and tumor progression, which could lead to a class of better cancer drugs. Back to top